Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases
Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases have?
Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases has 441 citations in the OpenAlex counts ScholarIQ stores.
When was Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases published?
Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases has 2012 year in the ScholarIQ index.
What is the open-access status of Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases?
Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases has hybrid oa status in the ScholarIQ index.
What is the DOI of Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases?
The DOI for Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases is on the source record.
What is the PMID of Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases?
The PMID for Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases is on the source record.
What is the OpenAlex record for Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases?
The OpenAlex for Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases is on the source record.